Suppr超能文献

老年人前列腺增生的潜在不适当处方。

Potentially Inappropriate Prescribing for Prostatic Hyperplasia in Older Persons.

机构信息

Department of Geriatric Medicine, CHU Amiens-Picardie, Amiens, France.

Department of Urology and Transplantation, CHU Amiens-Picardie, Amiens, France; EPROAD Laboratory EA 4669, Picardie Jules Verne University, Amiens, France.

出版信息

J Am Med Dir Assoc. 2022 Jun;23(6):992-997. doi: 10.1016/j.jamda.2021.09.023. Epub 2021 Oct 13.

Abstract

OBJECTIVES

In the context of improved medication management of older patients, we wished to evaluate the overprescription of potentially inappropriate drugs [α1-blockers and 5α-reductase inhibitors (5-ARI)] for benign prostate hyperplasia (BPH). These drugs are considered by geriatricians to increase the risk of falls and pharmacodynamic interactions, but these properties have not yet been proven.

DESIGN

This was a descriptive study of drug prescriptions in a geriatric academic center.

SETTING AND PARTICIPANTS

We included all patients older than 75 years who received a prescription for α1-blockers or 5-ARIs for 2 weeks in our hospital.

METHODS

We evaluated the prevalence of the potentially inappropriate prescription of α1-blockers and 5-ARI in older people during hospitalization using a new tool consisting of an 8-item list of explicit indicators developed using the most recent summary of product characteristics (SmPC) and latest European Association of Urology (EAU) guidelines.

RESULTS

A population of 117 patients (≥75 years) was included in the study. The median age was 84.5 (±6.3) years. The average time since urological medication prescription was 1.2 ± 1.6 years. According to explicit criteria, 84 patients (71.8%) received at least 1 potentially inappropriate urologic medication, 77 (91.7%) related to α1-blockers. Patients with a potentially inappropriate prescription for α1-blockers and/or 5-ARIs more frequently had urological assessments (P = .026), more frequently showed pharmacological interactions, with the risk of orthostatic hypotension (P = .005) or arrhythmia (P = .028), and experienced more falls in their history (P = .043). The misuse group was associated with an increased risk of falls, with an odds ratio of 3.22 (P = .039, 95% confidence interval 1.08-10.2).

CONCLUSIONS AND IMPLICATIONS

In our study, potentially inappropriate prescriptions for older individuals for BPH was close to 72% and mainly involved α1-blockers. Potentially inappropriate prescriptions for BPH were associated with a threefold higher frequency of falls.

摘要

目的

在改善老年患者药物管理的背景下,我们评估了用于治疗良性前列腺增生(BPH)的潜在不适当药物(α1-受体阻滞剂和 5α-还原酶抑制剂(5-ARI))的过度处方情况。老年病医生认为这些药物会增加跌倒和药效学相互作用的风险,但这些特性尚未得到证实。

设计

这是一项在老年医学学术中心进行的药物处方描述性研究。

地点和参与者

我们纳入了所有在我院住院期间接受α1-受体阻滞剂或 5-ARI 处方治疗 2 周的 75 岁以上患者。

方法

我们使用一种新工具评估了住院期间老年人潜在不适当的α1-受体阻滞剂和 5-ARI 处方的流行情况,该工具由根据最新药物特性摘要(SmPC)和最新欧洲泌尿外科学会(EAU)指南制定的 8 项明确指标清单组成。

结果

共纳入 117 名(≥75 岁)患者。中位年龄为 84.5(±6.3)岁。距泌尿科药物处方的平均时间为 1.2±1.6 年。根据明确标准,84 名(71.8%)患者至少接受了一种潜在不适当的泌尿科药物治疗,其中 77 名(91.7%)与α1-受体阻滞剂有关。接受α1-受体阻滞剂和/或 5-ARI 潜在不适当处方的患者更频繁地进行泌尿科评估(P=0.026),更频繁地出现药物相互作用,体位性低血压风险增加(P=0.005)或心律失常(P=0.028),且既往跌倒史更多(P=0.043)。误用组与跌倒风险增加相关,优势比为 3.22(P=0.039,95%置信区间 1.08-10.2)。

结论和意义

在我们的研究中,用于治疗老年 BPH 的潜在不适当处方接近 72%,主要涉及α1-受体阻滞剂。BPH 的潜在不适当处方与跌倒频率增加三倍相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验